SK Biopharmaceuticals Co., Ltd. - Pharmaceuticals & Healthcare - Deals and Alliances Profile - GlobalData Financial Mergers and Acquisitions Intelligence

SK Biopharmaceuticals Co., Ltd. - Pharmaceuticals & Healthcare - Deals and Alliances Profile

SK Biopharmaceuticals Co., Ltd. - Pharmaceuticals & Healthcare - Deals and Alliances Profile - GlobalData Financial Mergers and Acquisitions Intelligence
SK Biopharmaceuticals Co., Ltd. - Pharmaceuticals & Healthcare - Deals and Alliances Profile
Published Sep 23, 2016
22 pages — Published Sep 23, 2016
Price US$ 250.00  |  Buy this Report Now

About This Report

  
Abstract:

Summary

SK Biopharmaceuticals Co., Ltd. (SK Biopharmaceuticals), a subsidiary of SK Holdings Co., Ltd. is a pharmaceutical company that develops and markets innovative drugs for the treatment of central nervous system. The company offers plumiaz, SKL-N05 and JZP-110; YKP3089, relenopride, SKL-PD, SKL-A4R, SKL-PSY and FZ-016; SKL-ADHD and carisbamate drugs. It provides research and development; biological studies, lead compound development, preclinical studies and phase development services. The company offers development of next-generation drugs that maintains efficacy and minimizes side-effects and toxicity by harnessing life science technologies in new drug and development programs.

SK Biopharmaceuticals Co., Ltd. - Pharmaceuticals & Healthcare - Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharmaceuticals & Healthcare eTrack deals database, and primary and secondary research.


Scope

- Financial Deals - Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year - Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type - Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region - Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector - Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals - Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company's (major public companies) key financial metrics and ratios.
- Business Description - A brief description of the company's operations.
- Key Employees - A list of the key executives of the company.
- Important Locations and Subsidiaries - A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors - A list of the key competitors of the company.
- Key Recent Developments - A brief on recent news about the company.


Reasons to Buy

Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements
- The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company's business segments' expansion / divestiture strategy
- The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.

Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have sh

  
Source:
Document ID
GDPH350699D
Industry
Format:
PDF Adobe Acrobat
Buy Now

Sections

TitleStarting PageNumber of Pages
Table of Contents23
  List of Tables31
  List of Figures41
SK Biopharmaceuticals Co., Ltd., Pharmaceuticals &Healthcare, Deals By Year, 2010 to YTD 201642
SK Biopharmaceuticals Co., Ltd., Pharmaceuticals &Healthcare Deals By Type, 2010 to YTD 201661
SK Biopharmaceuticals Co., Ltd., Pharmaceuticals &Healthcare, Deals By Region, 2010 to YTD 201671
SK Biopharmaceuticals Co., Ltd., Pharmaceuticals &Healthcare, Deals By Therapy Area, 2010 to YTD 201681
SK Biopharmaceuticals Co., Ltd., Medical Devices Deals, 2010 to YTD 201691
SK Biopharmaceuticals Co., Ltd., Pharmaceuticals &Healthcare, Deals Summary, 2010 to YTD 2016101
SK Biopharmaceuticals Co., Ltd., Pharmaceuticals &Healthcare, Deal Details118
  Partnerships111
    SK Biopharma And AriBio Enter Into Co-Development Agreement For SKL-G111
    SK Biopharma Enters Into Co-Development Agreement With SK Chemicals For YKP-10811121
    SK Biopharma Enters Into Co-Development Agreement With PKU International HealthCare And Shanghai Medicilon132
    SK BioPharma Enters Co-Development Agreement With Shanghai Meidiclon151
    Mayo Clinic Enters Into Research Agreement With SK BioPharma162
  Acquisition181
    SK Holdings to Acquire SK Biotech from SK Biopharmaceuticals181
SK Biopharmaceuticals Co., Ltd. - Key Competitors191
Key Employees201
Locations And Subsidiaries211
  Head Office211
  Other Locations &Subsidiaries211
Appendix221
  Methodology221
  About GlobalData221
  Contact Us221
  Disclaimer221

Table Of Contents

About the Author


Cite this Report

  
MLA:
GlobalData Financial Mergers and Acquisitions Intelligence. "SK Biopharmaceuticals Co., Ltd. - Pharmaceuticals & Healthcare - Deals and Alliances Profile" Sep 23, 2016. Alacra Store. Nov 16, 2026. <http://www.alacrastore.com/storecontent/GlobalData-Financial-Mergers-and-Acquisitions-Intelligence/SK-Biopharmaceuticals-Co-Ltd-Pharmaceuticals-Healthcare-Deals-and-Alliances-Profile-2148-10424>
  
APA:
GlobalData Financial Mergers and Acquisitions Intelligence. (2016). SK Biopharmaceuticals Co., Ltd. - Pharmaceuticals & Healthcare - Deals and Alliances Profile Sep 23, 2016. New York, NY: Alacra Store. Retrieved Nov 16, 2026 from <http://www.alacrastore.com/storecontent/GlobalData-Financial-Mergers-and-Acquisitions-Intelligence/SK-Biopharmaceuticals-Co-Ltd-Pharmaceuticals-Healthcare-Deals-and-Alliances-Profile-2148-10424>
  
US$ 250.00
$  £  €
Have a Question?

Any questions about the report you're considering? Our Customer Service Team can help! Or visit our FAQs.

More Research